Rachel Pessah-Pollack, MD March 15, 2022 Rachel Pessah-Pollack, MD With #Ozempic and #ozempic weightloss continuing to trend on social media, along with the mainstream media focusing on celebrities who rely on Ozempic (semaglutide) for weight loss, the daily requests for this new medication have been increasing. Accompanying these requests are concerns and questions about potential...
Tag: <span>thyroid cancer</span>
Post
TikTok’s Fave Weight Loss Drugs: Link to Thyroid Cancer?
Rachel Pessah-Pollack, MD March 15, 2023 EDITORIAL COLLABORATION MEDSCAPE With #Ozempic and #ozempicweightloss continuing to trend on social media, along with the mainstream media focusing on celebrities who rely on Ozempic (semaglutide) for weight loss, the daily requests for this new medication have been increasing. Rachel Pessah-Pollack, MD Accompanying these requests are concerns and questions about potential...
Post
Researchers examine link between pesticides and thyroid cancer risk in Central California area
by University of California, Los Angeles Trends in the use of glyphosate compounds, oxyfluorfen, paraquat dichloride, naled, and benomyl in California, 1979-2012. Credit: The Journal of Clinical Endocrinology & Metabolism (2022). DOI: 10.1210/clinem/dgac413 In single pollutant models and within a 20-year period, 10 out of 29 reviewed pesticides were associated with thyroid cancer, including several of the most...
Post
Thyroid cancer now diagnosed with AI photoacoustic/ultrasound imaging
by Pohang University of Science & Technology A schematic diagram of acquiring the photoacoustic signal generated when laser light is irradiated to a malignant thyroid nodule with an ultrasonic sensor. Credit: POSTECH A lump in the thyroid gland is called a thyroid nodule, and 5-10% of all thyroid nodules are diagnosed as thyroid cancer. Thyroid...
Post
Filipino-Americans: Vitamin D binding protein in thyroid cancer health disparities
IMPACT JOURNALS LLC IMAGE: Cell counting and invasion assays after DBP-upregulation. (A) Cell counting at 0, 24, 48, and 72 hrs. after DBP overexpression compared to empty vector used as a control, a significantly lower cell count noted at 48 and 72 hrs. (*p < 0.05; **p < 0.01; ***p < 0.001), respectively. (B) A...
Post
In-utero exposures associated with increased risk of thyroid cancer
by University of Bergen Credit: Unsplash/CC0 Public Domain A recent study by prof. Tone Bjørge, University of Bergen, and her team shows that thyroid cancer is related to in-utero exposures. Thyroid cancer is diagnosed at a younger age than most other malignancies and the incidence is higher in women than men. “The only established modifiable risk factors for thyroid...
Post
Study finds that high levels of a growth factor increases risk for several cancers
by University of Oxford Electron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer Institute A study of almost 400,000 British participants has identified a new link between raised levels of the growth factor IGF-1 and increased thyroid cancer risk and has confirmed associations with breast, prostate and colorectal cancer. This could lead...
Post
New test for thyroid cancer could prevent unnecessary surgery
by University of Texas at Austin Researchers at The University of Texas at Austin and Baylor College of Medicine have developed a new preoperative test for thyroid cancer that is faster and about two-thirds more accurate than the diagnostic tests doctors use today. Although more validation will be necessary before it can be used clinically, the new metabolic thyroid test shows promise for preventing thousands of unnecessary thyroid removals each...
Post
Are doctors treating more thyroid cancer patients than necessary?
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer THOMAS JEFFERSON UNIVERSITY PHILADELPHIA — Nearly a million Americans live with thyroid cancer and doctors will diagnose more than 50,000 new cases this year. Fortunately, the survival rate for this kind of cancer is one of the best. Five years after diagnosis, more than...
Post
Drug duo approved for aggressive thyroid cancer
(HealthDay)—Two anti-cancer drugs administered together have been approved by the U.S. Food and Drug Administration to treat an inherited form of thyroid cancer. Tafinlar (dabrafenib) and Mekinist (trametinib) combined have been approved to treat anaplastic thyroid cancer caused by an abnormal BRAF V600E gene, the agency said Friday in a news release. Anaplastic thyroid cancer is a rare, yet...